In Europe, 2.4 million patients undergo high-risk surgery every year and while surgery is safer today than ever – it is not totally risk free, Evidence suggest that death during surgery is now rare but the 30 days after the procedure are crucial – more than 1 in 100 adults (1.5%) die in the first 30 days following their operation.
During high-risk surgery it is vital that blood continues to flow to organs. If blood pressure drops, and organs do not get enough blood, the higher the risk of severe postoperative complications, such as myocardial injury, acute kidney injury, and increased mortality, These drops in blood pressure are known as intraoperative hypotension (IOH) and are common – particularly in more senior patients. As little as a minute of IOH can increase the risk of patient harm or death and there is low awareness of this urgent issue among patients, clinicians, and policy makers. However, if IOH is effectively monitored and managed, many of these issues can be reduced or avoided. In addition, the need to improve perioperative care has been accentuated by the pandemic, which has put pressure on hospital capacity.
This webinar will present an overview of the challenges to drug development from the standpoint of the need for new sources of evidence. It will also include a presentation on what the 'RWE Navigator' is, and what it does with a live demonstration of the web tool.
DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.
WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.
June 29, 2016, Philadelphia
Europe and the US are experimenting with ways to develop therapies based on their actual ‘real world’ performance. This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.
Harnessing electronic health records and real world evidence to create new therapies more efficiently is quickly becoming a reality. How do we maximize the benefits offered by harnessing available health data while solving issues around its reuse and work with regulators to provide the right evidence?.
This webinar will provide the opportunity for participants to receive the latest updates on key outputs from the IMI GetReal project. Part of the IMI GetReal project has focused on exploring how best to tackle effectiveness research before marketing authorisation.
This webinar on “Synthesis and integration of real-world evidence in network meta-analyses and outcome prediction” will give the participants an understanding of important methodological key deliverables achieved by the IMI GetReal team.
This event is by invitation only. On February 8th, 2016, Vital Transformation will host a private VIP Dinner and Reception featuring speaker Sebastian Schneeweiss, Professor of Medicine at Harvard Medical School and Professor of Epidemiology at the Harvard School of Public Health.